- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01667835
South Asian Women & Yoga Education Study (SAWYES)
16 novembre 2012 mis à jour par: Dr. Amandah Hoogbruin, Kwantlen Polytechnic University
Yoga for Post-menopausal South Asian Women at Risk for Cardiovascular Disease: A Randomized Control Pilot Study
The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease.
Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques.
The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.
Aperçu de l'étude
Statut
Inconnue
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Anticipé)
50
Phase
- La phase 1
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
British Columbia
-
Surrey, British Columbia, Canada, V3T 0G9
- Recrutement
- The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic
-
Contact:
- Amandah L Hoogbruin, PhD
- Numéro de téléphone: 604 599 3144
- E-mail: amandah.hoogbruin@kwantlen.ca
-
Contact:
- Raymond Dong, FRCP(c)
- Numéro de téléphone: 604 686 6372
- E-mail: raydongheart@gmail.com
-
Surrey, British Columbia, Canada, V3W 2M8
- Pas encore de recrutement
- Kwantlen Polytechnic University
-
Contact:
- Amandah L Hoogbruin, PhD
- Numéro de téléphone: 604 599 3144
- E-mail: amandah.hoogbruin@kwantlen.ca
-
Contact:
- Raymond Dong, FRCPC
- Numéro de téléphone: 604 838 8418
- E-mail: raydongcardio@gmail.com
-
Chercheur principal:
- Amandah L Hoogbruin, PhD
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
40 ans à 65 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Oui
Sexes éligibles pour l'étude
Femelle
La description
Inclusion Criteria:
- 40- 65 years old
- Postmenopausal (amenorrhea for ≥ 12 months)
- Overweight as evidenced by a body mass index (BMI) ≥ 25 kg/m2), or waist circumference ≥ 80 cm, or have a first degree relative with diabetes or essential hypertension
- Sedentary, do not do a regular exercise program (exercising for 20 minutes at sufficient intensity to produce sweating less than 2x/week)
- Self-identify as a South Asian (sometimes referred to as East Indian in Canada and may be defined "as any person who reports an ethnicity associated with the southern part of Asia or who self-identifies as part of the South Asian visible minority group. This definition encompasses people from a great diversity of ethnic backgrounds, including those with Bangladeshi, Bengali, East Indian, Goan, Gujarati, Hindu, Ismaili, Kashmiri, Nepali, Pakistani, Punjabi, Sikh, Sinhalese, South Asian, Sri Lankan and Tamil ancestry. South Asians may have been born in Canada, on the Indian sub-continent, in the Caribbean, in Africa, in Great Britain or elsewhere
- Given consent to research protocol and willingness to be randomized to either the treatment (yoga) or control (no yoga) group.
Exclusion Criteria:
- Have had a period within the last year
- Are not between the ages of 40 and 65
- Have experience with yoga within the last 12 months
- Have any serious disease or condition such as diabetes, serious high blood pressure or heart problems, kidney disease, severe asthma, cancer (except for skin cancer that is not melanoma)
- Have a major brain or nervous system diagnosis, such as Parkinson's disease or stroke
- Have a severe infectious or other medical illness right now such as pneumonia
- Use medications to lower blood sugar levels
- Have serious back, hip, or neck problems or pain in joints or bones that would prevent the safe completion of a gentle 12 week Hatha yoga program
- Regularly use an assistive device (e.g., cane, walker) to walk
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Contrôler
|
|
|
Expérimental: Intervention de yoga
|
12 week 90 minute hatha yoga session offered three (3x) per week.
Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques.
The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in blood pressure
Délai: baseline, at end of study (12 wks), & 3 months post-study
|
blood pressure is measured as a specific physiologic index of cardiovascular risk.
|
baseline, at end of study (12 wks), & 3 months post-study
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in subjective well-being
Délai: baseline, at end of study (12 wks), & 3 months post-study
|
The Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being.
|
baseline, at end of study (12 wks), & 3 months post-study
|
|
Change in perceived physical well-being
Délai: baseline, end of study (12 wks) & 3 months post-study
|
Pittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in insulin sensitivity
Délai: baseline, end of study (12 wks) & 3 months post-study
|
Fasting insulin & glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in inflammation
Délai: baseline, end of study (12 wks) & 3 months post-study
|
C-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum total cholesterol
Délai: baseline, end of study (12 wks) & 3 months post-study
|
Serum total cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum high-density lipoprotein (HDL) cholesterol
Délai: baseline, end of study (12 wks) & 3 months post-study
|
Serum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum low-density lipoprotein (LDL) cholesterol
Délai: baseline, end of study (12 wks) & 3 months post-study
|
Serum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in serum triglycerides
Délai: baseline, end of study (12 wks) & 3 months post-study
|
Serum triglycerides will be measured as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in waist circumference.
Délai: baseline, end of study (12 wks) & 3 months post-study
|
Waist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change waist-hip ratio
Délai: baseline, end of study (12 wks) & 3 months post-study
|
Waist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in body mass index (BMI)
Délai: baseline, end of study (12 wks) & 3 months post-study
|
Body mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in resting heart rate
Délai: baseline, end of study (12 wks) & 3 months post-study
|
Resting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
|
baseline, end of study (12 wks) & 3 months post-study
|
|
Change in heart rate
Délai: baseline, at end of study (12 wks), & 3 months post-study
|
Heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
|
baseline, at end of study (12 wks), & 3 months post-study
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: Amandah L Hoogbruin, PhD, Kwantlen Polytechnic University
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 novembre 2012
Achèvement primaire (Anticipé)
1 décembre 2014
Achèvement de l'étude (Anticipé)
1 août 2015
Dates d'inscription aux études
Première soumission
17 juin 2012
Première soumission répondant aux critères de contrôle qualité
14 août 2012
Première publication (Estimation)
17 août 2012
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
19 novembre 2012
Dernière mise à jour soumise répondant aux critères de contrôle qualité
16 novembre 2012
Dernière vérification
1 novembre 2012
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- KK11-04
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .